BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Strides Pharma Science Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532531
ISIN Demat
INE939A01011
Book Value (Rs)
356.2353295
NSE Symbol
STAR
Divident Yield %
0.42
Market Cap
(Rs In Cr.)
11,086
P/E (TTM)
61.55
EPS (TTM)
19.54
Face Value
(Rs)
10
Back
Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter
31-Jul-26   Hrs IST

Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales1265.411119.74 13
OPM %18.0619.48 -
PBDT192.82179.30 8
PBT136.42130.41 5
NP156.9199.61 58

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)